InsidersTradesSigma
모아라이프플러스 Stock: price and insider trades · South Korea · DART (FSS)
Track the 모아라이프플러스 share price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 모아라이프플러스 has recorded 30 insider filings. Market capitalisation: €16.7bn. The latest transaction was disclosed on 9 July 2026 (Other). Among the most active insiders: 모아데이타. The full history is accessible without an account.
30
Insider Decl.
0
Thresholds
·
4 ops.
Buy Volume
·
1 ops.
Sell Volume
7Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 25,616 of 26,212 companies
10.4
score / 100
Value5
Quality16
FCF yld-37%
Earn yld-78%
EV/EBITDA·
ROE-22%
Gross mgn17%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 9 July 2026
Declarations30 total
25 of 30 declarations
About 모아라이프플러스
모아라이프플러스 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX. It focuses on developing innovative solutions to enhance patients' quality of life.